Nothing lasts forever. And it seems my knee is one of those things.
So, I’m scheduled for total knee replacement surgery on Wednesday, August 2nd.
A study by Johns Hopkins researchers shows that a fifth of U.S. neurologists appear unaware of serious drug safety risks associated with various anti-epilepsy drugs, potentially jeopardizing the health of patients who could be just as effectively treated with safer alternative medications.
The World Health Organization (WHO) is about to confirm what we’ve known for decades.
Aspartame can cause cancer.
Here’s the scandal…
Surprised?
With the legalization of smoking cannabis both for medical and recreational use, it’s clear marijuana’s time has come.
The jury is no longer out. States have been weighing in. And the answer has been a resounding : “Yes”.
Nearly half of U.S. adults have tried marijuana. A massive shift that took place over just a few years.
Going through trauma is not rare. About 6 out of every 10 (or 60%) of men and 5 of every 10 (or 50%) of women experience at least one trauma in their lives…
Reports of people who have seizures after vaping have raised serious questions about the safety of electronic cigarettes, which have grown in popularity in recent years.
The first Vagus Nerve Stimulator (VNS) was implanted in 1988, as a therapeutic option for medically intractable epilepsy, when elective epilepsy surgery was not appropriate.
As the number of implanted vagus nerve stimulators grows, so does the need to remove or revise the devices.
Which is a little tricky, because of the spiral stimulating electrodes, wrapped around the nerve.
Especially if the VNS treatment has proven ineffective.
And of course, what goes in, must come out.
Anyway you look at it, there’s more surgery involved.
Long-term use of Xcopri was safe and reduced seizures by more than 90% in adults with uncontrolled focal seizures, according to results of an open-label extension study published in Neurology.
“Compared with 2008, costs for brand-name anti seizure meds (ASMs), rose from approximately $2,800 to $10,700 per year in 2018, while costs for generic brand ASMs dropped $800 to $460. As a result, many generic ASMs cost about 10 times less than their brand-name counterparts…”